RAPP
Rapport Therapeutics Inc.
$30.27
+$1.49(+5.18%)
56
Overall
60
Value
66
Tech
44
Quality
Market Cap
$1.37B
Volume
312.88K
52W Range
$6.43 - $42.27
Target Price
$51.50
EPS Estimates Overview
| Current Quarter | $-0.65 | Next Quarter | $-0.75 |
| Current Year | $-2.79 | Next Year | $-3.41 |
| QoQ Growth | -15.4% | YoY Growth | -22.2% |
| 3Y EPS CAGR | N/A | Target Price | $51.50 |
| Consensus | Buy | Upside | +70.1% |
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RAPP | $30.27 | +5.2% | 312.88K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Rapport Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW